Olamkicept May Induce Response in IBD Patients
NEW YORK (Reuters Health) – Olamkicept, an interleukin (IL)-6 trans-signaling inhibitor, was well tolerated and induced a clinical response in […]
NEW YORK (Reuters Health) – Researchers have identified the process by which adherent-invasive Escherichia coli (AIEC) bacteria drive inflammation in […] A few years ago, as immunologist Gwendalyn Randolph, PhD, and postdoctoral researcher Li-Hao “Paul” Huang, PhD, hashed out a research […]Inflammatory Bowel Disease (IBD)
Adherent-Invasive E. Coli Metabolism Drives Inflammation in Crohn’s Disease
Washington People: Gwen Randolph